News

Rhinolast Allergy is a non-steroid treatment and is suitable for children from as young as five years old. Meda Pharma claims Rhinolast Allergy targets the symptoms of red,

The company has reported net earnings of $104.55m, compared to $94.27m for the same period prior year. For the first quarter of 2011, Mylan‘s earnings from operations was

Pro-Pharma’s lead product candidate Davanat is a carbohydrate polymer that targets Galectin proteins that are over-expressed by cancer cells and interferes with their activity. According to studies, Galectins

As per the agreement, ALDA Pharma’s personnel will undertake the marketing and sales of Seavan’s products and services in addition to those of ALDA. ALDA Pharma president and

With this acquisition, Hikma Pharma expects to enhance its Injectables platform across the world. Following the acquisition, Hikma will divest two West-Ward products, Phenytoin and Promethazine, as required

Net income attributable to the company was $2.22bn for the first quarter of 2011, compared to $2.02bn for the same period last year. For full-year 2011, Pfizer anticipated

Catalyst Rx Mobile is an element of Catalyst’s Generic Advantage plan, developed after more than a year of consultation with experts in the areas of pharmacy, behavioral psychology

TCGRx said MedPickRx system addresses the entire bottle formulary and reduces script fill time for the pharmacy’s entire oral solid formulary by up to 40% which represents 92%

The catalyst for the GlucALite launch was the completion of GLS Sciences randomized, double blind, placebo controlled pilot study, which confirmed that when used as part of diet,